Back
ESC Premium Access

Cost-effectiveness of canakinumab to prevent recurrent cardiovascular events

Session: Poster Session 3 - Health economics
Topic: Health Economics
Speaker: Doctor T. Sehested (Copenhagen, DK)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Thomas Steen Gyldenstierne Sehested

Herlev and Gentofte Hospital, Copenhagen (Denmark)
0 follower

9 more presentations in this session

Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe

Speaker: Professor K. Kotseva (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Cost comparison of transfemoral aortic valve replacement with balloon-expandable prosthesis performed in a reduced versus extended heart team

Speaker: Doctor M. Droppa (Tuebingen, DE)

Access
Abstract
Like
Thumbnail

Sodium nitrite-mediated cardioprotection in primary percutaneous coronary intervention for ST-elevation myocardial infarction: a cost-effectiveness analysis

Speaker: Doctor D. Jones (London, GB)

Access
Abstract
Like
Thumbnail

Is trancatheter aortic valve replacement a profitable procedure in a high-volume european hospital?

Speaker: Doctor F. Huchet (Saint-Nazaire, FR)

Access
Abstract
Slides
Like
Thumbnail

Economic and clinical outcomes of hospital care in patients with cardiac amyloidosis

Speaker: Ms T. Quock (South San Francisco, US)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 3 - Health economics

Speakers: Doctor T. Sehested, Professor K. Kotseva, Doctor M. Droppa, Doctor D. Jones, Doctor F. Huchet...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources